During the past decade, Complejo Hospitalario San Pablo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario San Pablo" are "Coronavirus Disease 2019" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Complejo Hospitalario San Pablo" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario San Pablo" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Carrimycin" (1 trials), "Pimodivir 600 mg" (1 trials) and "SOC Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario San Pablo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Complejo Hospitalario San Pablo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Complejo Hospitalario San Pablo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario San Pablo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".